2025 annual financial data
Galectin Therapeutics 2025 Operating margin
Direct answer
Operating margin was Not calculable.
Operating income was -20,085,000 USD and net income was -30,836,000 USD.
Operating cash flow was -23,875,000 USD.
Get free Galectin Therapeutics email updates.
Bullstory sends one daily email when new analysis or important company news is available.
Verified data
- Revenue
- 0 USD
- Operating income
- -20,085,000 USD
- Net income
- -30,836,000 USD
- Operating cash flow
- -23,875,000 USD